US20020090386A1 - Skin barrier composition - Google Patents

Skin barrier composition Download PDF

Info

Publication number
US20020090386A1
US20020090386A1 US10/043,767 US4376702A US2002090386A1 US 20020090386 A1 US20020090386 A1 US 20020090386A1 US 4376702 A US4376702 A US 4376702A US 2002090386 A1 US2002090386 A1 US 2002090386A1
Authority
US
United States
Prior art keywords
percent
weight
lotion
skin
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/043,767
Inventor
Joseph Haslwanter
William Rencher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/043,767 priority Critical patent/US20020090386A1/en
Publication of US20020090386A1 publication Critical patent/US20020090386A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585Organosilicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/895Polysiloxanes containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/896Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
    • A61K8/898Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/75Anti-irritant

Definitions

  • the present invention pertains to compositions which protect the skin against the effects of irritants, and more particularly to compositions which can be applied to the skin for protection against contact with body fluids and wastes.
  • the skin normally is capable of maintaining adequate internal moisture to remain pliable. This condition typically requires an internal relative humidity (“RH”) at least about 60 percent.
  • RH relative humidity
  • exposure to external moisture sources can cause a depletion of skin lipids and a consequential dermatitis. This condition is aggravated when the external moisture source also contains irritating chemicals, such as are present in body wastes.
  • the invention resides in a barrier lotion comprising: about 5 to 15 percent by weight of a long-chain fatty acid; about 1 to 5 percent by weight of a long-chain fatty alcohol; about 1 to 10 percent by weight of a hydrocarbon oil; about 1 to 30 percent by weight of a silicone skin protectant; about 0.5 to about 5 percent by weight of an alkanolamine; about 0.5 to about 5 percent by weight of a humectant; about 0.5 to about 10 percent by weight of an inorganic skin protectant; about 0.5 to 15 weight percent of a preservative; and about 50 to 90 percent by weight water.
  • a very desirable additional component is up to about 5 percent by weight of a fragrance, odor neutralizer or a mixture thereof.
  • percent is intended to mean, unless the context clearly indicates otherwise, percentages by weight.
  • formulation components are identified herein by their adopted names as given by J. M. Nikitakis et al., Eds., CTFA International Cosmetic Ingredient Dictionary , Fourth Ed., The Cosmetic, Toiletry and Fragrance Association, Washington, D.C., 1991.
  • the functions performed by various components are listed by J. A. Wenninger et al., Eds., CTFA Cosmetic Ingredient Handbook , Second Ed., The Cosmetic, Toiletry and Fragrance Association, Washington, D.C., 1992.
  • the invention encompasses skin barrier lotions comprising: about 5 to 15 percent by weight of a long-chain fatty acid; about 1 to 5 percent by weight of a long-chain fatty alcohol; about 1 to 10 percent by weight of a hydrocarbon oil; about 1 to 30 percent by weight of a silicone skin protectant; about 0.5 to about 5 percent by weight of an alkanolamine; about 0.5 to about 5 percent by weight of a humectant; about 0.5 to about 10 percent by weight of an inorganic skin protectant; about 0.5 to 15 weight percent of a preservative; and about 50 to 90 percent by weight water.
  • a fragrance odor “neutralizer” or mixtures thereof are also included up to about 5 weight percent of a fragrance odor “neutralizer” or mixtures thereof.
  • the long-chain fatty acid is generally a substituted or unsubstituted carboxylic acid, having carbon atoms (inclusive of the carboxy group) numbering about 12 to about 22.
  • the acid must be chosen from those which are safe for prolonged skin contact when formulated in water-external emulsions according to the general teachings herein.
  • the acids generally should have melting points higher than the temperature of the skin to which the barrier lotion is applied, so that the acid will be at least partially in solid form after application to the skin; the solid phase permits the acid to give a “dry” feel to the skin and facilitates the occlusive function of the acid.
  • Preferred normal carboxylic acids for purposes of the invention include, without limitation, lauric acid, myristic acid, palmitic acid, stearic acid, arachidic acid and tricosanoic acid.
  • the unsaturated acids will have melting points too low to be preferred for this invention.
  • Concentrations of the acid are generally about 5 to 15 percent, preferably about 8 to 11 percent.
  • the inventors presently have a preference for stearic acid, particularly in the “triple pressed” purity grade to obtain a product having consistent properties.
  • alkanolamine component is desired, as this material can react with the long chain fatty acid to form an emulsifier of the type frequently used to produce cosmetic skin creams and lotions.
  • alkanolamines can be used, including ethanolamine, diethanolamine, triethanolamine, isopropanolamine, diisopropanolamine, triisopropanolamine, methylethanolamine and others.
  • About 0.5 to 5 percent alkanolamine will be present in the formulation, preferably about 1 to 2 percent.
  • the long chain fatty acid content should be adjusted, such that an excess of fatty acid is present over that amount which will completely react with the alkanolamine to form a salt; sufficient excess acid should be used to produce a formulation having pH values approximating that of the skin, i.e., averaging about 5 to 6.
  • the choice of triethanolamine is preferred, as the emulsifier salt formed from these components gives a very desirable lotion product in accordance with the invention.
  • a further required component is the long chain fatty alcohol, being branched or unbranched, substituted or unsubstituted, and having about 14 to about 22 carbon atoms.
  • This component also provides an occlusive effect and, for obtaining the desired “dry” feel on the skin, should have a melting point higher than the temperature of the skin.
  • Preferred normal alcohols include myristyl alcohol, cetyl alcohol and stearyl alcohol.
  • the alcohol component is typically present in a barrier lotion at concentrations of about 1 to about 5 percent, and more preferably about 1 to about 4 percent.
  • a hydrocarbon oil or plant- or animal-derived oil is included in a formulation as a skin conditioning agent to maintain an appropriate moisture level within the skin, and may act as a humectant to assist in controlling the rate of water loss from the emulsion film as it is being applied.
  • Mineral oil has been found preferable for this purpose, and is generally present at about 1 to about 10 percent. Preferred concentrations are about 0.5 to about 5 percent. The amount of this component should be minimized, to prevent an oily feel on the skin and to facilitate removal of the film, when desired.
  • Mineral oils are available in a wide range of specific gravity and viscosity specifications, most of which are suitable for use in the invention; however, users generally prefer the skin feel of compositions having the lower specific gravities and viscosities.
  • humectants such as glycerol, ethylene or propylene glycols, sorbitol, mannitol and other hygroscopic substances will be included, as necessary to inhibit moisture loss from the formulation as it is being applied. Without sufficient humectant, the insoluble solids (e.g., stearic acid and cetyl alcohol) tend to not spread evenly as the emulsion breaks down from evaporative water losses; this results in aggregation of the insoluble solids, which adversely affects the appearance and sensory quality of the film.
  • the humectant will normally be present in amounts about 0.5 to about 5 percent, preferably about 1 to about 2 percent of the formulation.
  • the silicone skin protectant component is included at levels about 1 to 30 percent, preferably about 4 to 10 percent, for its barrier properties.
  • all barrier ingredients will cause an oily or greasy sensation on the skin, with the very impervious petrolatums probably giving the most unpleasant feel.
  • a silicone material such as amodimethicone, cyclomethicone, hexadecyl methicone, dimethicone, methicone, vinyldimethicone and the like minimizes the oily sensation, which can be even further reduced by incorporating an effective amount of an inorganic skin protectant such as calamine, kaolin, zinc oxide, zinc carbonate and the like.
  • the inorganic skin protectant will be present in the formulation at about 0.5 to about 10 percent, preferably about 0.5 to about 3 percent.
  • Skin care emulsions usually contain a preservative, to prevent microbial proliferation during storage and use of the product. This effect is particularly important for the product of this invention, which during use may be in contact with fluids having a significant microbial content. It is therefore desirable to incorporate an excess of preservative, over that needed solely for product storage stability; generally about 0.5 to about 15 percent preservative will be included, preferably about 0.5 to about 5 percent.
  • Preservatives from at least the following chemical classes are suitable for use in the invention: phenols, alcohols, aldehydes, dyes, surfactants, furan derivatives, quinoline and isoquinoline derivatives, guanidines and amidines.
  • benzyl alcohol (preferred, due to its local anesthetic effect on the skin), DM DM hydantoin, imidazolidinyl urea, phenylethyl alcohol, benzalkonium chloride, and Quaternium-15.
  • the barrier lotion will also contain water, in amounts about 50 to about 90 percent. Such high water contents creates a “vanishing” sensation, i.e., it feels as though substantially all of the lotion is being incorporated into the skin during application. To achieve consistent formulation characteristics, it is preferable to use purified water, such as that which has been treated by deionization or reverse osmosis to remove dissolved solids.
  • An optional, but highly desirable, component is a fragrance or odor neutralizer. This is of readily apparent importance when the lotion is used under an absorptive pad or other incontinence device. Many of the pleasant fragrances commonly used in skin care products are suitable, and these may be present alone or in combination with an odor neutralizer or absorber. Odor neutralizers and absorbers are also useful as an alternative to a fragrance. The inventors have found that the proprietary deodorizer ORDENONETM sold by Belle-Aire Fragrances, Inc., Mundelein, Ill. U.S.A. is particularly effective for reducing the odors associated with incontinence.
  • ORDENONE is described in the supplier's literature as having a semi-rigid concave molecular structure which selectively captures malodorous volatile mercaptan, sulfide, amine and other compounds, but does not affect the customary fragrance additives. In general, up to about 5 percent fragrance or odor reducer, or a combination thereof, will be used in the lotion, preferably up to about 1 percent.
  • Barrier lotions prepared according to the invention have the following beneficial properties:
  • a kilogram batch of a skin barrier lotion is prepared using the following components: Component Grams Part A Stearic acid 97.5 Cetyl alcohol 24.375 Light mineral oil, NF 20 Dimethicone 60 Part B Water 724.625 Zinc oxide 10 Glycerol 15 Part C Water 15 Triethanolamine 15 Part D Benzyl alcohol 10 Lemon fragrance 0.5 Part E Odor neutralizer 8
  • the lotion is prepared by the steps of: (1) combining the Part A ingredients in a suitable vessel and heating the mixture, with stirring, to about 70-75° C. to form a smooth liquid; (2) continuing the mixing and maintaining the temperature as the Part B ingredients are added, to form a uniform dispersion; (3) recirculating about 2 percent of the vessel contents per minute through an in-line motionless mixer* and back into the original vessel for a period of about 30-45 minutes while maintaining the temperature; (4) mixing together the Part C ingredients, to form a clear solution; (5) slowly adding the step 4 solution to the step 3 dispersion, while maintaining the stirring, recirculation and temperature; (6) with continued mixing, allowing the dispersion to cool to ambient temperature, adding the Part D ingredients as the temperature passes through about 40° C. and adding the Part E ingredient as the temperature passes through about 30-35° C.; and (7) operating the recirculation through the in-line mixer for 20-25 minutes after all ingredients have been added, as the product continues to cool.
  • the mixer has mixing elements, each having four holes at oblique angles, disposed within a conduit such that a tetrahedral chamber is formed between the elements.

Abstract

A skin barrier lotion for protection against contact with irritants comprises: about 5 to 15 percent by weight of a long-chain fatty acid; about 1 to 5 percent by weight of a long-chain fatty alcohol; about 1 to 10 percent by weight of a hydrocarbon oil; about 1 to 30 percent by weight of a silicone skin protectant; about 0.5 to about 5 percent by weight of an alkanolamine; about 0.5 to about 5 percent by weight of a humectant; about 0.5 to about 10 percent by weight of an inorganic skin protectant; about 0.5 to 15 weight percent of a preservative; and about 50 to 90 percent by weight water. Optionally, the lotion will also contain up to about 5 percent by weight of a fragrance, odor neutralizer or a mixture thereof.

Description

    INTRODUCTION TO THE INVENTION
  • The present invention pertains to compositions which protect the skin against the effects of irritants, and more particularly to compositions which can be applied to the skin for protection against contact with body fluids and wastes. [0001]
  • A substantial fraction of the population suffers at some time from a form of incontinence. Incontinence is normal with infants, but frequently incontinence is also the result of aging or some other uncontrolled mental or physiologic process. Absorptive pads and impervious garment liners are available to contain the excreted wastes and prevent their leakage onto clothing, furniture and the like, but many of these tend to maintain the wastes in contact with skin for prolonged periods and cause dermatolologic problems. [0002]
  • The skin normally is capable of maintaining adequate internal moisture to remain pliable. This condition typically requires an internal relative humidity (“RH”) at least about 60 percent. Various factors, including the presence of lipid components in the skin, work to maintain proper RH values for most aspects of normal living. However, exposure to external moisture sources can cause a depletion of skin lipids and a consequential dermatitis. This condition is aggravated when the external moisture source also contains irritating chemicals, such as are present in body wastes. [0003]
  • The are commercially available products for coating the skin to prevent deleterious contact with chemical substances. Such products are generally called “barrier” creams, lotions or ointments and are based on impervious substances such as petrolatum, silicone greases, heavy oils, waxes and the like. Unfortunately, these materials leave a very greasy, sticky or oily uncomfortable coating on the skin and therefore are best suited as substitutes for vinyl or rubber gloves, applied just prior to exposure to detergents, industrial chemicals, etc. For application to the pubic and perianal regions of the body, many persons would prefer a substance similar to those lotions, creams and the like normally used for the typical non-barrier skin care products; these are commonly emulsions of the oil-in-water type, since the skin absorbs these formulations more readily than it does oil-external formulations and does not acquire a greasy or oily feel after application of the product. [0004]
  • Accordingly, it was undertaken by the present inventors to develop an oil-in-water barrier lotion formulation which, after application to the skin, promptly feels dry, smooth and non-oily, and which effectively inhibits skin irritation from prolonged contact with body wastes or other irritants. [0005]
  • SUMMARY OF THE INVENTION
  • The invention resides in a barrier lotion comprising: about 5 to 15 percent by weight of a long-chain fatty acid; about 1 to 5 percent by weight of a long-chain fatty alcohol; about 1 to 10 percent by weight of a hydrocarbon oil; about 1 to 30 percent by weight of a silicone skin protectant; about 0.5 to about 5 percent by weight of an alkanolamine; about 0.5 to about 5 percent by weight of a humectant; about 0.5 to about 10 percent by weight of an inorganic skin protectant; about 0.5 to 15 weight percent of a preservative; and about 50 to 90 percent by weight water. A very desirable additional component is up to about 5 percent by weight of a fragrance, odor neutralizer or a mixture thereof.[0006]
  • DETAILED DESCRIPTION OF THE INVENTION
  • Throughout this specification, the term “percent” is intended to mean, unless the context clearly indicates otherwise, percentages by weight. Various formulation components are identified herein by their adopted names as given by J. M. Nikitakis et al., Eds., [0007] CTFA International Cosmetic Ingredient Dictionary, Fourth Ed., The Cosmetic, Toiletry and Fragrance Association, Washington, D.C., 1991. The functions performed by various components are listed by J. A. Wenninger et al., Eds., CTFA Cosmetic Ingredient Handbook, Second Ed., The Cosmetic, Toiletry and Fragrance Association, Washington, D.C., 1992.
  • The invention encompasses skin barrier lotions comprising: about 5 to 15 percent by weight of a long-chain fatty acid; about 1 to 5 percent by weight of a long-chain fatty alcohol; about 1 to 10 percent by weight of a hydrocarbon oil; about 1 to 30 percent by weight of a silicone skin protectant; about 0.5 to about 5 percent by weight of an alkanolamine; about 0.5 to about 5 percent by weight of a humectant; about 0.5 to about 10 percent by weight of an inorganic skin protectant; about 0.5 to 15 weight percent of a preservative; and about 50 to 90 percent by weight water. Optionally, there also is included up to about 5 weight percent of a fragrance odor “neutralizer” or mixtures thereof. [0008]
  • The long-chain fatty acid is generally a substituted or unsubstituted carboxylic acid, having carbon atoms (inclusive of the carboxy group) numbering about 12 to about 22. Of course, the acid must be chosen from those which are safe for prolonged skin contact when formulated in water-external emulsions according to the general teachings herein. The acids generally should have melting points higher than the temperature of the skin to which the barrier lotion is applied, so that the acid will be at least partially in solid form after application to the skin; the solid phase permits the acid to give a “dry” feel to the skin and facilitates the occlusive function of the acid. Preferred normal carboxylic acids for purposes of the invention include, without limitation, lauric acid, myristic acid, palmitic acid, stearic acid, arachidic acid and tricosanoic acid. In general, the unsaturated acids will have melting points too low to be preferred for this invention. Concentrations of the acid are generally about 5 to 15 percent, preferably about 8 to 11 percent. [0009]
  • The inventors presently have a preference for stearic acid, particularly in the “triple pressed” purity grade to obtain a product having consistent properties. [0010]
  • An alkanolamine component is desired, as this material can react with the long chain fatty acid to form an emulsifier of the type frequently used to produce cosmetic skin creams and lotions. Several alkanolamines can be used, including ethanolamine, diethanolamine, triethanolamine, isopropanolamine, diisopropanolamine, triisopropanolamine, methylethanolamine and others. About 0.5 to 5 percent alkanolamine will be present in the formulation, preferably about 1 to 2 percent. The long chain fatty acid content should be adjusted, such that an excess of fatty acid is present over that amount which will completely react with the alkanolamine to form a salt; sufficient excess acid should be used to produce a formulation having pH values approximating that of the skin, i.e., averaging about 5 to 6. Particularly when the long chain fatty acid is stearic acid, the choice of triethanolamine is preferred, as the emulsifier salt formed from these components gives a very desirable lotion product in accordance with the invention. [0011]
  • A further required component is the long chain fatty alcohol, being branched or unbranched, substituted or unsubstituted, and having about 14 to about 22 carbon atoms. This component also provides an occlusive effect and, for obtaining the desired “dry” feel on the skin, should have a melting point higher than the temperature of the skin. Preferred normal alcohols include myristyl alcohol, cetyl alcohol and stearyl alcohol. The alcohol component is typically present in a barrier lotion at concentrations of about 1 to about 5 percent, and more preferably about 1 to about 4 percent. [0012]
  • A hydrocarbon oil or plant- or animal-derived oil is included in a formulation as a skin conditioning agent to maintain an appropriate moisture level within the skin, and may act as a humectant to assist in controlling the rate of water loss from the emulsion film as it is being applied. Mineral oil has been found preferable for this purpose, and is generally present at about 1 to about 10 percent. Preferred concentrations are about 0.5 to about 5 percent. The amount of this component should be minimized, to prevent an oily feel on the skin and to facilitate removal of the film, when desired. Mineral oils are available in a wide range of specific gravity and viscosity specifications, most of which are suitable for use in the invention; however, users generally prefer the skin feel of compositions having the lower specific gravities and viscosities. [0013]
  • Other humectants, such as glycerol, ethylene or propylene glycols, sorbitol, mannitol and other hygroscopic substances will be included, as necessary to inhibit moisture loss from the formulation as it is being applied. Without sufficient humectant, the insoluble solids (e.g., stearic acid and cetyl alcohol) tend to not spread evenly as the emulsion breaks down from evaporative water losses; this results in aggregation of the insoluble solids, which adversely affects the appearance and sensory quality of the film. The humectant will normally be present in amounts about 0.5 to about 5 percent, preferably about 1 to about 2 percent of the formulation. [0014]
  • The silicone skin protectant component is included at levels about 1 to 30 percent, preferably about 4 to 10 percent, for its barrier properties. However, all barrier ingredients will cause an oily or greasy sensation on the skin, with the very impervious petrolatums probably giving the most unpleasant feel. Using a silicone material, such as amodimethicone, cyclomethicone, hexadecyl methicone, dimethicone, methicone, vinyldimethicone and the like minimizes the oily sensation, which can be even further reduced by incorporating an effective amount of an inorganic skin protectant such as calamine, kaolin, zinc oxide, zinc carbonate and the like. The inorganic skin protectant will be present in the formulation at about 0.5 to about 10 percent, preferably about 0.5 to about 3 percent. [0015]
  • Skin care emulsions usually contain a preservative, to prevent microbial proliferation during storage and use of the product. This effect is particularly important for the product of this invention, which during use may be in contact with fluids having a significant microbial content. It is therefore desirable to incorporate an excess of preservative, over that needed solely for product storage stability; generally about 0.5 to about 15 percent preservative will be included, preferably about 0.5 to about 5 percent. Preservatives from at least the following chemical classes are suitable for use in the invention: phenols, alcohols, aldehydes, dyes, surfactants, furan derivatives, quinoline and isoquinoline derivatives, guanidines and amidines. Among the suitable preservatives specifically considered useful are benzyl alcohol (preferred, due to its local anesthetic effect on the skin), DM DM hydantoin, imidazolidinyl urea, phenylethyl alcohol, benzalkonium chloride, and Quaternium-15. [0016]
  • The barrier lotion will also contain water, in amounts about 50 to about 90 percent. Such high water contents creates a “vanishing” sensation, i.e., it feels as though substantially all of the lotion is being incorporated into the skin during application. To achieve consistent formulation characteristics, it is preferable to use purified water, such as that which has been treated by deionization or reverse osmosis to remove dissolved solids. [0017]
  • An optional, but highly desirable, component is a fragrance or odor neutralizer. This is of readily apparent importance when the lotion is used under an absorptive pad or other incontinence device. Many of the pleasant fragrances commonly used in skin care products are suitable, and these may be present alone or in combination with an odor neutralizer or absorber. Odor neutralizers and absorbers are also useful as an alternative to a fragrance. The inventors have found that the proprietary deodorizer ORDENONE™ sold by Belle-Aire Fragrances, Inc., Mundelein, Ill. U.S.A. is particularly effective for reducing the odors associated with incontinence. ORDENONE is described in the supplier's literature as having a semi-rigid concave molecular structure which selectively captures malodorous volatile mercaptan, sulfide, amine and other compounds, but does not affect the customary fragrance additives. In general, up to about 5 percent fragrance or odor reducer, or a combination thereof, will be used in the lotion, preferably up to about 1 percent. [0018]
  • Barrier lotions prepared according to the invention have the following beneficial properties: [0019]
  • (a) a lack of irritation potential, even for previously irritated skin; [0020]
  • (b) a “vanishing” sensation when applied to skin; [0021]
  • (c) a pearlescent appearance before being rubbed into the skin, which facilitates even applications; [0022]
  • (d) a “dry” feel, which becomes non-greasy a few seconds after rubbing into the skin; [0023]
  • (e) excellent barrier characteristics to water and body wastes; [0024]
  • (f) prompt removal with soap and water; and [0025]
  • (g) excellent physical stability. [0026]
  • The invention will be further described by means of the following example, which is not intended to limit the scope of the appended claims in any manner. [0027]
  • EXAMPLE
  • A kilogram batch of a skin barrier lotion is prepared using the following components: [0028]
    Component Grams
    Part A
    Stearic acid 97.5
    Cetyl alcohol 24.375
    Light mineral oil, NF 20
    Dimethicone 60
    Part B
    Water 724.625
    Zinc oxide 10
    Glycerol 15
    Part C
    Water 15
    Triethanolamine 15
    Part D
    Benzyl alcohol 10
    Lemon fragrance 0.5
    Part E
    Odor neutralizer 8
  • The lotion is prepared by the steps of: (1) combining the Part A ingredients in a suitable vessel and heating the mixture, with stirring, to about 70-75° C. to form a smooth liquid; (2) continuing the mixing and maintaining the temperature as the Part B ingredients are added, to form a uniform dispersion; (3) recirculating about 2 percent of the vessel contents per minute through an in-line motionless mixer* and back into the original vessel for a period of about 30-45 minutes while maintaining the temperature; (4) mixing together the Part C ingredients, to form a clear solution; (5) slowly adding the step [0029] 4 solution to the step 3 dispersion, while maintaining the stirring, recirculation and temperature; (6) with continued mixing, allowing the dispersion to cool to ambient temperature, adding the Part D ingredients as the temperature passes through about 40° C. and adding the Part E ingredient as the temperature passes through about 30-35° C.; and (7) operating the recirculation through the in-line mixer for 20-25 minutes after all ingredients have been added, as the product continues to cool.
  • * The mixer has mixing elements, each having four holes at oblique angles, disposed within a conduit such that a tetrahedral chamber is formed between the elements. [0030]

Claims (27)

What is claimed is:
1. A skin barrier lotion comprising: about 5 to 15 percent by weight of a long-chain fatty acid; about 1 to 5 percent by weight of a long-chain fatty alcohol; about 1 to 10 percent by weight of an oil; about 1 to 30 percent by weight of a silicone skin protectant; about 0.5 to about 5 percent by weight of an alkanolamine; about 0.5 to about 5 percent by weight of a humectant; about 0.5 to about 10 percent by weight of an inorganic skin protectant; about 0.5 to 15 weight percent of a preservative; and about 50 to 90 percent by weight water.
2. The lotion of claim 1, further comprising up to about 5 percent by weight of a fragrance, odor neutralizer or a mixture thereof.
3. The lotion of claim 1, wherein the fatty acid is a substituted or unsubstituted carboxylic acid having about 12 to 22 carbon atoms and a melting point higher than the temperature of skin to which the lotion is to be applied.
4. The lotion of claim 1, wherein the fatty acid is selected from the group consisting of lauric acid, myristic acid, palmitic acid, stearic acid, arachidic acid and tricosanoic acid.
5. The lotion of claim 1, wherein the fatty acid comprises stearic acid.
6. The lotion of claim 1, wherein the long chain fatty alcohol has about 14 to 22 carbon atoms and a melting point higher than the temperature of skin to which the lotion is to be applied.
7. The lotion of claim 1, wherein the long chain fatty alcohol is selected from the group consisting of myristyl alcohol, cetyl alcohol and stearyl alcohol.
8. The lotion of claim 1, wherein the long chain fatty alcohol comprises cetyl alcohol.
9. The lotion of claim 1, wherein the oil is selected from the group consisting of mineral oils, plant-derived oils and animal-derived oils.
10. The lotion of claim 1, wherein the oil comprises a light mineral oil.
11. The lotion of claim 1, wherein the silicone skin protectant is selected from the group consisting of as amodimethicone, cyclomethicone, hexadecyl methicone, dimethicone, methicone and vinyidimethicone.
12. The lotion of claim 1, wherein the silicone skin protectant comprises dimethicone.
13. The lotion of claim 1, wherein the alkanolamine is selected from the group consisting of ethanolamine, diethanolamine, triethanolamine, isopropanolamine, diisopropanolamine, triisopropanolamine and methylethanolamine.
14. The lotion of claim 1, wherein the alkanolamine comprises triethanolamine.
15. The lotion of claim 1, wherein the humectant is selected from the group consisting of glycerol, ethylene glycol, propylene glycol, sorbitol and mannitol.
16. The lotion of claim 1, wherein the humectant comprises glycerol.
17. The lotion of claim 1, wherein the inorganic skin protectant is selected from the group consisting of calamine, kaolin, zinc oxide and zinc carbonate.
18. The lotion of claim 1, wherein the inorganic skin protectant comprises zinc oxide.
19. The lotion of claim 1, wherein the preservative is selected from the group consisting of phenols, alcohols, aldehydes, dyes, surfactants, furan derivatives, quinoline and isoquinoline derivatives, guanidines and amidines.
20. The lotion of claim 1, wherein the preservative comprises an alcohol.
21. The lotion of claim 1, wherein the preservative comprises benzyl alcohol.
22. The lotion of claim 1, wherein the long chain fatty acid is present in stoichiometric excess over that amount needed to form a salt with the alkanolamine.
23. The lotion of claim 22, wherein the long chain fatty acid is present in amounts which produce lotion pH values about 5 to 6.
24. A skin barrier lotion comprising: about 8 to 11 percent by weight of a long-chain fatty acid; about 1 to 4 percent by weight of a long-chain fatty alcohol; about 0.5 to 5 percent by weight of an oil; about 4 to 8 percent by weight of a silicone skin protectant; about 1 to about 2 percent by weight of an alkanolamine; about 1 to about 2 percent by weight of a humectant; about 0.5 to about 3 percent by weight of an inorganic skin protectant; about 0.5 to 5 weight percent of a preservative; and about 50 to 90 percent by weight water.
25. The lotion of claim 24, further comprising up to about 1 percent by weight of a fragrance, odor neutralizer or a mixture thereof.
26. A skin barrier lotion comprising: about 8 to 11 percent by weight of stearic acid; about 1 to 4 percent by weight of cetyl alcohol; about 0.5 to 5 percent by weight of a light mineral oil; about 4 to 8 percent by weight of dimethicone; about 1 to about 2 percent by weight of triethanolamine; about 1 to about 2 percent by weight of glycerol; about 0.5 to about 3 percent by weight of zinc oxide; about 0.5 to 5 weight percent of benzyl alcohol; and about 50 to 90 percent by weight water.
27. The lotion of claim 26, further comprising up to about 1 percent by weight of a fragrance, odor neutralizer or a mixture thereof.
US10/043,767 1998-05-04 2002-01-10 Skin barrier composition Abandoned US20020090386A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/043,767 US20020090386A1 (en) 1998-05-04 2002-01-10 Skin barrier composition

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8418198P 1998-05-04 1998-05-04
US09/303,413 US6649175B1 (en) 1998-05-04 1999-05-03 Skin barrier composition
US10/043,767 US20020090386A1 (en) 1998-05-04 2002-01-10 Skin barrier composition

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/303,413 Continuation US6649175B1 (en) 1998-05-04 1999-05-03 Skin barrier composition

Publications (1)

Publication Number Publication Date
US20020090386A1 true US20020090386A1 (en) 2002-07-11

Family

ID=26770686

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/303,413 Expired - Fee Related US6649175B1 (en) 1998-05-04 1999-05-03 Skin barrier composition
US10/043,767 Abandoned US20020090386A1 (en) 1998-05-04 2002-01-10 Skin barrier composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/303,413 Expired - Fee Related US6649175B1 (en) 1998-05-04 1999-05-03 Skin barrier composition

Country Status (1)

Country Link
US (2) US6649175B1 (en)

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004004674A1 (en) * 2002-07-04 2004-01-15 Beiersdorf Ag Cosmetic preparation for treating dry and sensitive skin
US20040028708A1 (en) * 2002-08-08 2004-02-12 Brooks Joann Enzyme blocking skin protectant cream
US20060246026A1 (en) * 2003-07-01 2006-11-02 Brian Bennett Barrier formulation comprising a silicone based emulsion
WO2007031793A2 (en) * 2005-09-16 2007-03-22 Reckitt Benckiser (Uk) Limited Improvements in or relatimg to cosmetic compositions
US8343945B2 (en) 2007-12-07 2013-01-01 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8362091B2 (en) 2003-08-04 2013-01-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8435498B2 (en) 2002-10-25 2013-05-07 Foamix Ltd. Penetrating pharmaceutical foam
US8486375B2 (en) 2003-04-28 2013-07-16 Foamix Ltd. Foamable compositions
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US8518378B2 (en) 2003-08-04 2013-08-27 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US8709385B2 (en) 2008-01-14 2014-04-29 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US8722021B2 (en) 2002-10-25 2014-05-13 Foamix Ltd. Foamable carriers
US8795635B2 (en) 2006-11-14 2014-08-05 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9167813B2 (en) 2009-07-29 2015-10-27 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9320705B2 (en) 2002-10-25 2016-04-26 Foamix Pharmaceuticals Ltd. Sensation modifying topical composition foam
US9408810B2 (en) 2010-06-01 2016-08-09 Belle-Aire Frangrances, Inc. Oral odor control method and product
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US9622947B2 (en) 2002-10-25 2017-04-18 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8703212B2 (en) * 1999-09-03 2014-04-22 Viraj Shah, Varion Limited Base material for pharmaceutical and/or cosmetic cream (herbal composition for itchy or infected skin)
FR2816505B1 (en) * 2000-11-13 2003-05-02 Oreal USE OF CARBOHYDRATE TO IMPROVE THE BARRIER FUNCTION OF THE SKIN
US7887847B2 (en) * 2004-05-08 2011-02-15 Paul Jr Edward L Nutritional supplement for treatment of ocular diseases
US20060062749A1 (en) * 2004-09-16 2006-03-23 Shelton Michael C personal care products incorporating cellulosic fatty acid esters
US20070053855A1 (en) * 2004-09-16 2007-03-08 Shelton Michael C Personal care products incorporating cellulosic fatty acid esters
JP2011521890A (en) * 2007-12-21 2011-07-28 シェーリング−プラウ ヘルスケア プロダクツ,インコーポレイテッド Compositions and methods for reducing or preventing water loss from skin
US8211413B2 (en) * 2010-01-11 2012-07-03 You See, Llc Method and composition for preventing coloring of the skin adjacent the hairline when dying a person's hair

Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2189138A (en) * 1938-06-03 1940-02-06 Yellow Truck & Coach Mfg Co Rubber mounting
US2647289A (en) * 1950-08-24 1953-08-04 Kaiser Frazer Corp Window weatherstripping
US3363303A (en) * 1965-08-26 1968-01-16 P O Box 18992 Weatherstrip mounting hand tool
US3488828A (en) * 1967-11-30 1970-01-13 Ppg Industries Inc Means and method for inserting a structural gasket locking strip
US3550242A (en) * 1968-03-11 1970-12-29 Standard Products Co Lock strip inserting tool
US4092394A (en) * 1975-11-05 1978-05-30 Dixon International Limited Manufacture of draught excluders
US4165083A (en) * 1977-03-11 1979-08-21 Draftex Development Ag Arrangements for retaining and sealing window glass
US4172313A (en) * 1977-02-24 1979-10-30 Yoshida Kogyo K.K. Gasket installing device
US4185371A (en) * 1978-01-12 1980-01-29 Barnett Melvin L Beading installation tool
US4614347A (en) * 1984-01-27 1986-09-30 Draftex Industries, Limited Assembled trimming and sealing strip
US4620354A (en) * 1985-05-28 1986-11-04 General Motors Corporation Method of applying weatherstrip to a vehicle body opening
US4716641A (en) * 1986-06-19 1988-01-05 Shrimpton Ronald J Truck windshield moulding insertion tool
US4738482A (en) * 1985-02-21 1988-04-19 Rockwell-Golde G.M.B.H. Rigid lid for an automobile roof
US4897913A (en) * 1986-07-18 1990-02-06 General Motors Corporation Method of using a robot for installing weather stripping in a door or like opening
US4996756A (en) * 1988-02-10 1991-03-05 Draftex Industries Limited Apparatus for fitting sealing and trimming strips
US5010689A (en) * 1990-03-19 1991-04-30 The Standard Products Company Glass run channel
US5115551A (en) * 1989-09-06 1992-05-26 Draftex Industries, Limited Method for fitting a flexible strip
US5462292A (en) * 1992-11-30 1995-10-31 Nishikawa Rubber Co., Ltd. Door seal device
US6785948B2 (en) * 2001-02-02 2004-09-07 Industrie Ilpea S.P.A. Method and apparatus for assembling in an automated manner a sealing profile on an inner door for refrigerators
US6874218B2 (en) * 2002-07-25 2005-04-05 Pilkington North America, Inc. Apparatus and method for attaching a seal to an encapsulated window assembly

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443855B1 (en) * 1991-09-18 1998-02-10 Revlon Consumer Prod Corp Cosmetics and pharmaceuticals containing extensins and related methods
US5378468A (en) * 1992-09-22 1995-01-03 The Mennen Company Composition containing body activated fragrance for contacting the skin and method of use

Patent Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2189138A (en) * 1938-06-03 1940-02-06 Yellow Truck & Coach Mfg Co Rubber mounting
US2647289A (en) * 1950-08-24 1953-08-04 Kaiser Frazer Corp Window weatherstripping
US3363303A (en) * 1965-08-26 1968-01-16 P O Box 18992 Weatherstrip mounting hand tool
US3488828A (en) * 1967-11-30 1970-01-13 Ppg Industries Inc Means and method for inserting a structural gasket locking strip
US3550242A (en) * 1968-03-11 1970-12-29 Standard Products Co Lock strip inserting tool
US4092394A (en) * 1975-11-05 1978-05-30 Dixon International Limited Manufacture of draught excluders
US4172313A (en) * 1977-02-24 1979-10-30 Yoshida Kogyo K.K. Gasket installing device
US4165083A (en) * 1977-03-11 1979-08-21 Draftex Development Ag Arrangements for retaining and sealing window glass
US4185371A (en) * 1978-01-12 1980-01-29 Barnett Melvin L Beading installation tool
US4614347A (en) * 1984-01-27 1986-09-30 Draftex Industries, Limited Assembled trimming and sealing strip
US4738482A (en) * 1985-02-21 1988-04-19 Rockwell-Golde G.M.B.H. Rigid lid for an automobile roof
US4620354A (en) * 1985-05-28 1986-11-04 General Motors Corporation Method of applying weatherstrip to a vehicle body opening
US4716641A (en) * 1986-06-19 1988-01-05 Shrimpton Ronald J Truck windshield moulding insertion tool
US4897913A (en) * 1986-07-18 1990-02-06 General Motors Corporation Method of using a robot for installing weather stripping in a door or like opening
US4996756A (en) * 1988-02-10 1991-03-05 Draftex Industries Limited Apparatus for fitting sealing and trimming strips
US5115551A (en) * 1989-09-06 1992-05-26 Draftex Industries, Limited Method for fitting a flexible strip
US5010689A (en) * 1990-03-19 1991-04-30 The Standard Products Company Glass run channel
US5462292A (en) * 1992-11-30 1995-10-31 Nishikawa Rubber Co., Ltd. Door seal device
US6785948B2 (en) * 2001-02-02 2004-09-07 Industrie Ilpea S.P.A. Method and apparatus for assembling in an automated manner a sealing profile on an inner door for refrigerators
US6874218B2 (en) * 2002-07-25 2005-04-05 Pilkington North America, Inc. Apparatus and method for attaching a seal to an encapsulated window assembly

Cited By (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
WO2004004674A1 (en) * 2002-07-04 2004-01-15 Beiersdorf Ag Cosmetic preparation for treating dry and sensitive skin
US20040028708A1 (en) * 2002-08-08 2004-02-12 Brooks Joann Enzyme blocking skin protectant cream
WO2004014331A1 (en) * 2002-08-08 2004-02-19 Kimberly-Clark Worldwide, Inc. Enzyme blocking skin protectant cream
US6932976B2 (en) 2002-08-08 2005-08-23 Kimberly-Clark Worldwide, Inc. Enzyme blocking skin protectant cream
US9713643B2 (en) 2002-10-25 2017-07-25 Foamix Pharmaceuticals Ltd. Foamable carriers
US10821077B2 (en) 2002-10-25 2020-11-03 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10322085B2 (en) 2002-10-25 2019-06-18 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US9320705B2 (en) 2002-10-25 2016-04-26 Foamix Pharmaceuticals Ltd. Sensation modifying topical composition foam
US8435498B2 (en) 2002-10-25 2013-05-07 Foamix Ltd. Penetrating pharmaceutical foam
US8741265B2 (en) 2002-10-25 2014-06-03 Foamix Ltd. Penetrating pharmaceutical foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8722021B2 (en) 2002-10-25 2014-05-13 Foamix Ltd. Foamable carriers
US11033491B2 (en) 2002-10-25 2021-06-15 Vyne Therapeutics Inc. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9622947B2 (en) 2002-10-25 2017-04-18 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8840869B2 (en) 2002-10-25 2014-09-23 Foamix Ltd. Body cavity foams
US9492412B2 (en) 2002-10-25 2016-11-15 Foamix Pharmaceuticals Ltd. Penetrating pharmaceutical foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8486375B2 (en) 2003-04-28 2013-07-16 Foamix Ltd. Foamable compositions
US20060246026A1 (en) * 2003-07-01 2006-11-02 Brian Bennett Barrier formulation comprising a silicone based emulsion
US9050253B2 (en) 2003-08-04 2015-06-09 Foamix Pharmaceuticals Ltd. Oleaginous pharmaceutical and cosmetic foam
US9101662B2 (en) 2003-08-04 2015-08-11 Foamix Pharmaceuticals Ltd. Compositions with modulating agents
US8518378B2 (en) 2003-08-04 2013-08-27 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9636405B2 (en) 2003-08-04 2017-05-02 Foamix Pharmaceuticals Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8703105B2 (en) 2003-08-04 2014-04-22 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8362091B2 (en) 2003-08-04 2013-01-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
WO2007031793A3 (en) * 2005-09-16 2008-06-12 Reckitt Benckiser Uk Ltd Improvements in or relatimg to cosmetic compositions
US8524207B2 (en) 2005-09-16 2013-09-03 Reckitt Benckiser (Uk) Limited Cosmetic compositions
US20090117068A1 (en) * 2005-09-16 2009-05-07 Reckitt & Benckiser (Uk) Limited Cosmetic compositions
WO2007031793A2 (en) * 2005-09-16 2007-03-22 Reckitt Benckiser (Uk) Limited Improvements in or relatimg to cosmetic compositions
US9682021B2 (en) 2006-11-14 2017-06-20 Foamix Pharmaceuticals Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8795635B2 (en) 2006-11-14 2014-08-05 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9662298B2 (en) 2007-08-07 2017-05-30 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US11103454B2 (en) 2007-08-07 2021-08-31 Vyne Therapeutics Inc. Wax foamable vehicle and pharmaceutical compositions thereof
US10369102B2 (en) 2007-08-07 2019-08-06 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US8900553B2 (en) 2007-12-07 2014-12-02 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US9549898B2 (en) 2007-12-07 2017-01-24 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US11433025B2 (en) 2007-12-07 2022-09-06 Vyne Therapeutics Inc. Oil foamable carriers and formulations
US8343945B2 (en) 2007-12-07 2013-01-01 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US9161916B2 (en) 2007-12-07 2015-10-20 Foamix Pharmaceuticals Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US9795564B2 (en) 2007-12-07 2017-10-24 Foamix Pharmaceuticals Ltd. Oil-based foamable carriers and formulations
US8709385B2 (en) 2008-01-14 2014-04-29 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US10588858B2 (en) 2009-04-28 2020-03-17 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10213384B2 (en) 2009-04-28 2019-02-26 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10363216B2 (en) 2009-04-28 2019-07-30 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US9572775B2 (en) 2009-07-29 2017-02-21 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US11219631B2 (en) 2009-07-29 2022-01-11 Vyne Pharmaceuticals Inc. Foamable compositions, breakable foams and their uses
US9167813B2 (en) 2009-07-29 2015-10-27 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US10092588B2 (en) 2009-07-29 2018-10-09 Foamix Pharmaceuticals Ltd. Foamable compositions, breakable foams and their uses
US10350166B2 (en) 2009-07-29 2019-07-16 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US10137200B2 (en) 2009-10-02 2018-11-27 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10517882B2 (en) 2009-10-02 2019-12-31 Foamix Pharmaceuticals Ltd. Method for healing of an infected acne lesion without scarring
US10238746B2 (en) 2009-10-02 2019-03-26 Foamix Pharmaceuticals Ltd Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10265404B2 (en) 2009-10-02 2019-04-23 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8865139B1 (en) 2009-10-02 2014-10-21 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10322186B2 (en) 2009-10-02 2019-06-18 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US8945516B2 (en) 2009-10-02 2015-02-03 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US8992896B2 (en) 2009-10-02 2015-03-31 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US9675700B2 (en) 2009-10-02 2017-06-13 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10463742B2 (en) 2009-10-02 2019-11-05 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10213512B2 (en) 2009-10-02 2019-02-26 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US10610599B2 (en) 2009-10-02 2020-04-07 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10821187B2 (en) 2009-10-02 2020-11-03 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10835613B2 (en) 2009-10-02 2020-11-17 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
US10967063B2 (en) 2009-10-02 2021-04-06 Vyne Therapeutics Inc. Surfactant-free, water-free formable composition and breakable foams and their uses
US10086080B2 (en) 2009-10-02 2018-10-02 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US9408810B2 (en) 2010-06-01 2016-08-09 Belle-Aire Frangrances, Inc. Oral odor control method and product
US10849847B2 (en) 2016-09-08 2020-12-01 Foamix Pharamaceuticals Ltd. Compositions and methods for treating rosacea and acne
US11324691B2 (en) 2016-09-08 2022-05-10 Journey Medical Corporation Compositions and methods for treating rosacea and acne
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne

Also Published As

Publication number Publication date
US6649175B1 (en) 2003-11-18

Similar Documents

Publication Publication Date Title
US6649175B1 (en) Skin barrier composition
US4970220A (en) Skin conditioning composition
US4478853A (en) Skin conditioning composition
US5436007A (en) Diaper rash lotion
US5336692A (en) Ointment base and method of use
CA1129774A (en) Anhydrous multi-purpose moisturizing composition
US4529605A (en) Bathing oil composition
US4355046A (en) Dermatologic and cosmetic ointment base
US5362488A (en) Buffered diaper rash cream
KR100635243B1 (en) Skin care composition with improved skin hydration capability
US5738859A (en) Cosmetic composition
EP0330369A1 (en) Skin conditioning composition
NZ233666A (en) Antimicrobial alcohol-containing gel composition which also contains moisturising and skin conditioning agents
JP3026568B2 (en) Emulsion formulations, emulsion mixtures and methods for their preparation
JPH0421642B2 (en)
US4263274A (en) Antiperspirant compositions and methods
CA2270670A1 (en) Skin barrier composition
EP3226827B2 (en) Aluminium-free antiperspirant/deodorant compositions and method of preparing the same
MXPA99004113A (en) Composition of barrier to the p
JP3532713B2 (en) Skin cosmetics
JPS61207326A (en) Skin treating composition
US20040120975A1 (en) Biliquid foam emulsions of water and hydrofluoroether as cosmetic carriers
KR20000009651A (en) Silicon emulsion type aqueous gel cosmetic composition with good sebum removal performance and cosmetic maintenance
US9561164B2 (en) High lubrication shaving aid
JP2022045971A (en) Oil-in-water type emulsion composition

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION